BOTOX VISTA® (onabotulinumtoxinA) for Masseter Muscle Prominence: A Phase 3, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study
Latest Information Update: 25 Sep 2025
At a glance
- Drugs Botulinum-Toxin-A (Primary)
- Indications Hypertrophy
- Focus Adverse reactions; Registrational; Therapeutic Use
- Acronyms MMP Japan 080
- Sponsors AbbVie
Most Recent Events
- 22 Aug 2025 Status changed from active, no longer recruiting to completed.
- 18 Oct 2024 Planned primary completion date changed from 10 Jan 2026 to 23 Dec 2025.
- 18 Oct 2024 Status changed from recruiting to active, no longer recruiting.